Interventions to reduce major vascular complications of TAVR

References

• Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106(24), 3006–3008 (2002).
   PubMed Web of Science ®Google Scholar
• Cribier A, Eltchaninoff H, Tron C et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J. Am. Coll. Cardiol. 43(4), 698–703 (2004).
   PubMed Web of Science ®Google Scholar
• Webb JG, Chandavimol M, Thompson CR et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113(6), 842–850 (2006).
   PubMed Web of Science ®Google Scholar
• Grube E, Laborde JC, Gerckens U et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114(15), 1616–1624 (2006).
   PubMed Web of Science ®Google Scholar
• Lichtenstein SV, Cheung A, Ye J et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 114(6), 591–596 (2006).
   PubMed Web of Science ®Google Scholar
• Fraccaro C, Napodano M, Tarantini G et al. Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system. JACC. Cardiovasc. Interv. 2(9), 828–833 (2009).
   PubMed Web of Science ®Google Scholar
• Bapat V, Attia R. Transaortic transcatheter aoirtic valve implantation: step-by-step guide. Semin. Thorac. Cardiovasc. Surg. 24(3), 206–211 (2012).
   PubMedGoogle Scholar
• Hayashida K, Lefèvre T, Chevalier B et al. True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications. JACC Cardiovasc. Interv. 5(2), 207–214 (2012).
   PubMed Web of Science ®Google Scholar
• Toggweiler S, Gurvitch R, Leipsic J et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J. Am. Coll. Cardiol. 59(2), 113–118 (2012).
   PubMed Web of Science ®Google Scholar
• Stortecky S, Wenaweser P, Diehm N et al. Percutaneous management of vascular complications in patients undergoing transcatheter aortic valve implantation. JACC Cardiovasc. Interv. 5(5), 515–524 (2012).
   PubMed Web of Science ®Google Scholar
• Thomas M, Schymik G, Walther T et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 124(4), 425–433 (2011).
   PubMed Web of Science ®Google Scholar
• Généreux P, Webb JG, Svensson LG et al.; PARTNER Trial Investigators. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J. Am. Coll. Cardiol. 60(12), 1043–1052 (2012).
   PubMed Web of Science ®Google Scholar
• Kappetein AP, Head SJ, Généreux P et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J. Am. Coll. Cardiol. 60(15), 1438–1454 (2012).
   PubMed Web of Science ®Google Scholar
• Leipsic J, Wood D, Manders D et al. The evolving role of MDCT in transcatheter aortic valve replacement: a radiologists’ perspective. AJR Am. J. Roentgenol. 193(3), W214–W219 (2009).
   PubMed Web of Science ®Google Scholar
• Collins R, Burch J, Cranny G et al. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ 334(7606), 1257 (2007).
   PubMedGoogle Scholar
• Généreux P, Head SJ, Wood DA et al. Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur. Heart J. 33(19), 2388–2398 (2012).
   PubMed Web of Science ®Google Scholar
• Nietlispach F, Leipsic J, Al-Bugami S, Masson JB, Carere RG, Webb JG. CT of the ilio–femoral arteries using direct aortic contrast injection: proof of feasibility in patients screened towards percutaneous aortic valve replacement. Swiss Med. Wkly 139(31–32), 458–462 (2009).
   PubMed Web of Science ®Google Scholar
• Joshi SB, Mendoza DD, Steinberg DH et al. Ultra-low-dose intra-arterial contrast injection for iliofemoral computed tomographic angiography. JACC Cardiovasc. Imaging 2(12), 1404–1411 (2009).
   PubMed Web of Science ®Google Scholar
• Owen AR, Roditi GH. Peripheral arterial disease: the evolving role of non-invasive imaging. Postgrad. Med. J. 87(1025), 189–198 (2011).
   PubMed Web of Science ®Google Scholar
• Murphy KJ, Brunberg JA, Cohan RH. Adverse reactions to gadolinium contrast media: a review of 36 cases. AJR Am. J. Roentgenol. 167(4), 847–849 (1996).
   PubMed Web of Science ®Google Scholar
• Auerbach EG, Martin ET. Magnetic resonance imaging of the peripheral vasculature. Am. Heart J. 148(5), 755–763 (2004).
   PubMed Web of Science ®Google Scholar
• Swan JS, Kennell TW, Acher CW et al. Magnetic resonance angiography of aorto-iliac disease. Am. J. Surg. 180(1), 6–12 (2000).
   PubMed Web of Science ®Google Scholar
• Thomsen HS. Nephrogenic systemic fibrosis: history and epidemiology. Radiol. Clin. North Am. 47(5), 827–831, vi (2009).
   PubMed Web of Science ®Google Scholar
• Iozzelli A, D’Orta G, Aliprandi A, Secchi F, Di Leo G, Sardanelli F. The value of true-FISP sequence added to conventional gadolinium-enhanced MRA of abdominal aorta and its major branches. Eur. J. Radiol. 72(3), 489–493 (2009).
   PubMed Web of Science ®Google Scholar
• Arthurs ZM, Starnes BW, Sohn VY, Singh N, Andersen CA. Ultrasound-guided access improves rate of access-related complications for totally percutaneous aortic aneurysm repair. Ann. Vasc. Surg. 22(6), 736–741 (2008).
   PubMed Web of Science ®Google Scholar
• Carere RG, Webb JG, Ahmed T, Dodek AA. Initial experience using Prostar: a new device for percutaneous suture-mediated closure of arterial puncture sites. Cathet. Cardiovasc. Diagn. 37(4), 367–372 (1996).
   PubMedGoogle Scholar
• Krajcer Z, Howell M. A novel technique using the percutaneous vascular surgery device to close the 22 French femoral artery entry site used for percutaneous abdominal aortic aneurysm exclusion. Catheter Cardiovasc. Interv. 50(3), 356–360 (2000).
   PubMed Web of Science ®Google Scholar
• Jahnke T, Schäfer JP, Charalambous N et al. Total percutaneous endovascular aneurysm repair with the dual 6-F Perclose-AT preclosing technique: a case-control study. J. Vasc. Interv. Radiol. 20(10), 1292–1298 (2009).
   PubMed Web of Science ®Google Scholar
• Starnes BW, Andersen CA, Ronsivalle JA, Stockmaster NR, Mullenix PS, Statler JD. Totally percutaneous aortic aneurysm repair: experience and prudence. J. Vasc. Surg. 43(2), 270–276 (2006).
   PubMed Web of Science ®Google Scholar
• Lee WA, Brown MP, Nelson PR, Huber TS. Total percutaneous access for endovascular aortic aneurysm repair (‘Preclose’ technique). J. Vasc. Surg. 45(6), 1095–1101 (2007).
   PubMed Web of Science ®Google Scholar
• Van Mieghem NM, Nuis RJ, Piazza N et al. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. EuroIntervention 5(6), 673–679 (2010).
   PubMed Web of Science ®Google Scholar
• Tchetche D, Dumonteil N, Sauguet A et al. Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population. EuroIntervention 5(6), 659–665 (2010).
   PubMed Web of Science ®Google Scholar
• Ussia GP, Barbanti M, Petronio AS et al.; CoreValve Italian Registry Investigators. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur. Heart J. 33(8), 969–976 (2012).
   PubMed Web of Science ®Google Scholar
• Baim DS, Knopf WD, Hinohara T et al. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate and discharge (STAND I and STAND II) trials. Am. J. Cardiol. 85(7), 864–869 (2000).
   PubMed Web of Science ®Google Scholar
• Durand E, Borz B, Godin M et al. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc. Interv. 5(5), 461–467 (2012).
   PubMed Web of Science ®Google Scholar
• Rinder MR, Tamirisa PK, Taniuchi M, Kurz HI, Mumm K, Lasala JM. Safety and efficacy of suture-mediated closure after percutaneous coronary interventions. Catheter Cardiovasc. Interv. 54(2), 146–151 (2001).
   PubMed Web of Science ®Google Scholar
• Applegate RJ, Grabarczyk MA, Little WC et al. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J. Am. Coll. Cardiol. 40(1), 78–83 (2002).
   PubMed Web of Science ®Google Scholar
• Kahlert P, Al-Rashid F, Plicht B et al. Suture-mediated arterial access site closure after transfemoral aortic valve implantation. Catheter Cardiovasc. Interv. 81(2), E139–E150 (2013).
   Google Scholar
• Freeman M, Rodes-Cabau J, Urena M et al. First-in-man transfemoral transcatheter aortic valve replacement with the 29mm Edwards Sapien XT valve. Catheter Cardiovasc. Interv. doi:10.1002/ccd.24543 (2012) (Epub ahead of print).
   Google Scholar
• Genereux P, Kodali S, Leon MB et al. Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation. JACC Cardiovasc. Interv. 4(8), 861–867 (2011).
   PubMed Web of Science ®Google Scholar
• Buchanan GL, Chieffo A, Montorfano M et al. A ‘modified crossover technique’ for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation. Catheter Cardiovasc. Interv. 81(4), 579–583 (2013).
   PubMed Web of Science ®Google Scholar
• Sharp AS, Michev I, Maisano F et al. A new technique for vascular access management in transcatheter aortic valve implantation. Catheter Cardiovasc. Interv. 75(5), 784–793 (2010).
   PubMed Web of Science ®Google Scholar
• Généreux P, Head SJ, Van Mieghem NM et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J. Am. Coll. Cardiol. 59(25), 2317–2326 (2012).
   PubMed Web of Science ®Google Scholar
• Ducrocq G, Francis F, Serfaty JM et al. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. EuroIntervention 5(6), 666–672 (2010).
   PubMed Web of Science ®Google Scholar
• Tamburino C, Capodanno D, Ramondo A et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123(3), 299–308 (2011).
   PubMed Web of Science ®Google Scholar
• Rodés-Cabau J, Webb JG, Cheung A et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J. Am. Coll. Cardiol. 55(11), 1080–1090 (2010).
   PubMed Web of Science ®Google Scholar